According to published results, tranexamic acid use in high-risk patients during total hip arthroplasty (THA) and total knee arthroplasty (TKA) was associated with decreased odds of blood transfusion with no increased risk for complications.

Jashvant Poeran, MD, PhD, and colleagues at the Icahn School of Medicine at Mount Sinai analyzed three groups of patients who underwent either THA or TKA between 2013 and 2016 and were deemed high-risk for complications.

Source: Orthopedics Today

Read full article.